EarningsSILVAPHL
SILVAPHL Earnings Update
Announcement summary
- What happened
- SILVAPHL published a corporate disclosure on 3 May 2026. Read the full announcement for details.
- Company
- Silva Pharmaceuticals Limited
- Announcement published
Original announcement
(Q3 Un-audited): EPS was Tk. (0.20) for January-March 2026 as against Tk. (0.14) for January-March 2025; EPS was Tk. (0.72) for July 2025-March 2026 as against Tk. (0.57) for July 2024-March 2025. NOCFPS was Tk. 0.09 for July 2025-March 2026 as against Tk. 0.26 for July 2024-March 2025. NAV per share was Tk. 14.76 as on March 31, 2026 and Tk. 15.48 as on June 30, 2025. Reasons for decreased in EPS, NOCFPS and NAVPS: (cont.)
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 69f6c624f35b0b05d2b54777
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SILVAPHL
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.